
The Carlyle Group
http://www.carlyle.com/The Carlyle Group is one of the world’s largest private equity firms. The firm has more than $81.1 billion under management with 60 funds across four investment disciplines: buyouts, venture & growth capital, real estate and leveraged finance. Carlyle focuses on sectors including: aerospace & defense, automotive & transportation, consumer & retail, energy & power, financial services, healthcare, industrial, infrastructure, real estate, technology & business services and telecommunications & media. Carlyle employs more than 575 investment professionals, and its portfolio companies employ more than 286,000 people worldwide. The firm is based in Washington DC and has over 1200 investors in 68 countries.
View Older Stories
-
Azenta (AZTA) Announces Actions to Support Ongoing Strategic and Governance Transformation
-
Form 10-Q Carlyle Group Inc. For: Sep 30
-
The Carlyle Group (CG) Tops Q3 EPS by 15c
-
Form 8-K Carlyle Group Inc. For: Nov 07
-
Marpai, Inc. (MRAI) Appoints Damien Lamendola as CEO
-
Form 13F-HR Carlyle Group Inc. For: Sep 30
-
The Carlyle Group (CG) to Explore Sale of Every Man Jack - Reuters
-
The Carlyle Group's (CG) Net Health Appoints Ron Books as CEO
-
Form SC 13D/A SOLENO THERAPEUTICS INC Filed by: Carlyle Group Inc.
-
Form SC 13D/A Carlyle Group Management Filed by: Carlyle Group Management L.L.C.
-
Form SC 13D/A SOLENO THERAPEUTICS INC Filed by: Carlyle Group Inc.
-
Form 3 Carlyle Group Inc. For: Oct 01 Filed by: Redett John C.
-
Carlyle Group in Exclusive Talks To Acquire Majority Stake in Medtronic's Patient Monitoring and Respiratory Intervention Units at a Valuation Of More Than $7B - Reuters
-
Form SC 13G Complete Solaria, Inc. Filed by: Carlyle Group Inc.
-
The Carlyle Group (CG) 30-day option implied volatility low
-
Form SC 13D/A Carlyle Credit Income Filed by: Carlyle Group Inc.
-
Form SC 13D/A Carlyle Credit Income Filed by: Carlyle Group Inc.
-
Form 4 Carlyle Group Inc. For: Aug 23 Filed by: SCHWARTZ HARVEY M
-
Form SC 13D/A eFFECTOR Therapeutics, Filed by: Carlyle Group Inc.
-
Form SC 13D/A SOLENO THERAPEUTICS INC Filed by: Carlyle Group Inc.
-
The Carlyle Group (CG) and Quest Global Enter Strategic Partnership
-
Form 13F-HR Carlyle Group Inc. For: Jun 30
-
Form 4 Carlyle Group Inc. For: Aug 02 Filed by: Finn Christopher
-
Form 4 Carlyle Group Inc. For: Aug 02 Filed by: Buser Curtis L.
-
Form 4 Carlyle Group Inc. For: Aug 02 Filed by: Larson Bruce M.
-
Form 4 Carlyle Group Inc. For: Aug 02 Filed by: Andrews Charles Elliott Jr.
-
Form 4 Carlyle Group Inc. For: Aug 02 Filed by: Ferguson Jeffrey W.
-
Form 144 Carlyle Group Inc. Filed by: Ferguson Jeffrey W.
-
Form 144 Carlyle Group Inc. Filed by: Finn Christopher
-
Form 144 Carlyle Group Inc. Filed by: Larson Bruce M.
-
Form 144 Carlyle Group Inc. Filed by: Buser Curtis L.
-
Form SC 13D/A Vera Therapeutics, Inc. Filed by: Carlyle Group Inc.
-
Form 10-Q Carlyle Group Inc. For: Jun 30
-
The Carlyle Group (CG) Tops Q2 EPS by 21c
-
Form 8-K Carlyle Group Inc. For: Aug 02
-
Form SC 13D/A Carlyle Credit Income Filed by: Carlyle Group Inc.
-
Form SC 13D/A Vera Therapeutics, Inc. Filed by: Carlyle Group Inc.
-
The Carlyle Group (CG) puts more active than calls
-
Form 8-K Carlyle Group Inc. For: Jun 20
-
Form S-8 Carlyle Group Inc.
-
Form 4 Carlyle Group Inc. For: Jun 01 Filed by: Cherwoo Sharda
-
Form 3 Carlyle Group Inc. For: Jun 01 Filed by: Cherwoo Sharda
-
Blue Bird Corporation (BLBD) Appoints Two New Members to its Board of Directors
-
Form 8-K Carlyle Group Inc. For: May 30
-
Form 4 Carlyle Group Inc. For: May 23 Filed by: SCHWARTZ HARVEY M
-
Omnicell (OMCL) Appoints Nchacha E. Etta as CFO
-
Form SC 13D/A SOLENO THERAPEUTICS INC Filed by: Carlyle Group Inc.
-
Form SC 13D/A Reneo Pharmaceuticals, Filed by: Carlyle Group Inc.
-
Form 13F-HR Carlyle Group Inc. For: Mar 31
-
Form 10-K/A Carlyle Group Inc. For: Dec 31